- Home
- TH vs REPL Comparison
TH vs REPL Comparison
Compare TH & REPL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TH
- REPL
- Stock Information
- Founded
- TH 1978
- REPL 2015
- Country
- TH United States
- REPL United States
- Employees
- TH N/A
- REPL N/A
- Industry
- TH Hotels/Resorts
- REPL Biotechnology: Pharmaceutical Preparations
- Sector
- TH Consumer Discretionary
- REPL Health Care
- Exchange
- TH Nasdaq
- REPL Nasdaq
- Market Cap
- TH 692.6M
- REPL 757.8M
- IPO Year
- TH N/A
- REPL 2018
- Fundamental
- Price
- TH $7.97
- REPL $11.09
- Analyst Decision
- TH Hold
- REPL Strong Buy
- Analyst Count
- TH 3
- REPL 7
- Target Price
- TH $11.25
- REPL $20.83
- AVG Volume (30 Days)
- TH 433.5K
- REPL 1.3M
- Earning Date
- TH 08-06-2025
- REPL 08-07-2025
- Dividend Yield
- TH N/A
- REPL N/A
- EPS Growth
- TH N/A
- REPL N/A
- EPS
- TH 0.43
- REPL N/A
- Revenue
- TH $349,497,000.00
- REPL N/A
- Revenue This Year
- TH N/A
- REPL N/A
- Revenue Next Year
- TH $9.98
- REPL N/A
- P/E Ratio
- TH $18.47
- REPL N/A
- Revenue Growth
- TH N/A
- REPL N/A
- 52 Week Low
- TH $4.00
- REPL $6.44
- 52 Week High
- TH $11.10
- REPL $17.00
- Technical
- Relative Strength Index (RSI)
- TH 70.35
- REPL 68.18
- Support Level
- TH $7.05
- REPL $9.26
- Resistance Level
- TH $8.24
- REPL $9.90
- Average True Range (ATR)
- TH 0.23
- REPL 0.59
- MACD
- TH 0.10
- REPL 0.14
- Stochastic Oscillator
- TH 78.66
- REPL 91.56
About TH Target Hospitality Corp.
Target Hospitality Corp is a vertically integrated specialty rental and hospitality services company in the United States. The company provides vertically integrated specialty rental and comprehensive hospitality services including catering food services, maintenance, housekeeping, grounds-keeping, on-site security, overall workforce lodge management, and laundry service. Its operating segment includes HFS-South and HFS-Midwest; Government; TCPL Keystone and others. It generates a majority of its revenue from the Government segment which consists of specialty rental and vertically integrated hospitality services revenue from customers with Government contracts located in Texas.
About REPL Replimune Group Inc.
Replimune Group Inc is a clinical-stage biotechnology company. It uses a proprietary RPx platform to design and develop product candidates that are intended to maximally activate the immune system against solid tumors. The RPx platform is based on a proprietary, engineered strain of herpes simplex virus 1, or HSV-1, backbone with payloads added to maximize immunogenic cell death and the induction of a systemic anti-tumor immune response. The company focuses on developing oncolytic immunotherapies for the treatment of cancer. Its pipeline products include RP1, RP2, and RP3. The company operates in USA and UK, majority of revenue from USA.